End of Day Message
LONDON, 11 Jan. 2024 (GLOBE NEWSWIRE) -- This is the End of Day Message for GlobeNewswire.
GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information provider.
Disclaimer
The content and accuracy of all information distributed through Notified is wholly the responsibility of the originator. Notified accepts no liability for any losses arising from reliance by any person upon the content of any announcement.
If you have any questions about this message, please Contact Us.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Crypto: Remittix Confirms November 24 RTX Launch as Ethereum Price Prediction Eyes $12,000 and Cardano’s Tokenized-Equity Push Revives the $1 ADA Dream
- Purina and Mariska Hargitay Bring the Purple Leash Project to U.S. Soccer, Launch Limited-Edition Scarves Supporting Abuse Survivors and Pets
- First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share